[1]
“MORTALITY AND ITS RISK FACTORS AMONG IN-PATIENTS WITH INVASIVE ASPERGILLOSIS TREATED WITH VORICONAZOLE”, SEATROPH, vol. 53, no. 2, pp. 142–150, Mar. 2022, Accessed: Apr. 16, 2026. [Online]. Available: https://journal.seameotropmednetwork.org/index.php/jtropmed/article/view/551